AMNEAL PHARMACEUTICALS INC (AMRX) Stock News

USA - Nasdaq - NASDAQ:AMRX - US03168L1052 - Common Stock

11.87 USD

-0.31 (-2.55%)

Last: 12/8/2025, 8:00:00 PM

11.92 USD

+0.05 (+0.42%)

Pre-Market: 12/9/2025, 6:28:42 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AMRX Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Amneal Pharmaceuticals LLC

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease

4 days ago - By: Amneal Pharmaceuticals LLC

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease

7 days ago - By: Amneal Pharmaceuticals LLC

Amneal to Participate in Upcoming Investor Conferences

11 days ago - By: Zacks Investment Research - Mentions: ANIP

ANIP vs. AMRX: Which Niche Drugmaker Is the Better Pick?

a month ago - By: Zacks Investment Research

Implied Volatility Surging for Amneal Pharmaceuticals Stock Options

a month ago - By: Benzinga - Mentions: IR CDP ENTG BUD ...

Earnings Scheduled For October 30, 2025

7 days ago - By: Amneal Pharmaceuticals LLC

Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

7 days ago - By: Amneal Pharmaceuticals LLC

Amneal to Participate in Upcoming Investor Conferences

8 days ago - By: Amneal Pharmaceuticals LLC

Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

8 days ago - By: Amneal Pharmaceuticals LLC

Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

11 days ago - By: The Motley Fool

Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares?

18 days ago - By: The Motley Fool

Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year Highs

18 days ago - By: Zacks Investment Research - Mentions: ANIP COLL

Why 2025 is a Dynamic and Transformative Year for Collegium

25 days ago - By: Zacks Investment Research - Mentions: TEVA ANIP VTRS

ANI Pharmaceuticals Stock Surges 53% YTD: Time to Buy or Sell?

26 days ago - By: Amneal Pharmaceuticals LLC

Amneal Receives U.S. FDA Approval for Iohexol Injection

26 days ago - By: Amneal Pharmaceuticals LLC

Amneal Receives U.S. FDA Approval for Iohexol Injection

a month ago - By: Zacks Investment Research

Amneal (AMRX) Reports Q3 Earnings: What Key Metrics Have to Say

a month ago - By: Amneal Pharmaceuticals LLC

Amneal Reports Third Quarter 2025 Financial Results

a month ago - By: Amneal Pharmaceuticals LLC

Amneal Reports Third Quarter 2025 Financial Results

a month ago - By: Amneal Pharmaceuticals LLC

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol

a month ago - By: Amneal Pharmaceuticals LLC

Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

a month ago - By: Amneal Pharmaceuticals LLC

Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches

2 months ago - By: Zacks Investment Research - Mentions: UTHR

Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for

2 months ago - By: Benzinga - Mentions: AMPH TEVA RDY VTRS

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs

2 months ago - By: Kashiv BioSciences, LLC and Amneal Pharmaceuticals, Inc. and Alvotech and Advanz Pharma - Mentions: ALVO

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)

2 months ago - By: Zacks Investment Research - Mentions: ANIX

Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?